These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25151653)

  • 1. Vitamin K antagonists and cognitive impairment: results from a cross-sectional pilot study among geriatric patients.
    Annweiler C; Ferland G; Barberger-Gateau P; Brangier A; Rolland Y; Beauchet O
    J Gerontol A Biol Sci Med Sci; 2015 Jan; 70(1):97-101. PubMed ID: 25151653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K Antagonists and Cognitive Decline in Older Adults: A 24-Month Follow-Up.
    Brangier A; Ferland G; Rolland Y; Gautier J; Féart C; Annweiler C
    Nutrients; 2018 May; 10(6):. PubMed ID: 29794977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K Antagonists and Cognitive Function in Older Adults: The Three-City Cohort Study.
    Ferland G; Feart C; Presse N; Lorrain S; Bazin F; Helmer C; Berr C; Annweiler C; Rouaud O; Dartigues JF; Fourrier-Reglat A; Barberger-Gateau P
    J Gerontol A Biol Sci Med Sci; 2016 Oct; 71(10):1356-62. PubMed ID: 26576841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
    Gaertner S; Cordeanu EM; Mirea C; Stephan D
    Int J Cardiol; 2015; 186():141-2. PubMed ID: 25818758
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease.
    Tavassoli N; Perrin A; Bérard E; Gillette S; Vellas B; Rolland Y;
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):425-33. PubMed ID: 23943094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prestroke use of vitamin K antagonists for atrial fibrillation - trends over 15 years.
    Bembenek JP; Karliński M; Kobayashi A; Członkowska A
    Int J Clin Pract; 2015 Feb; 69(2):180-5. PubMed ID: 25358816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.
    Le Heuzey JY; Ammentorp B; Darius H; De Caterina R; Schilling RJ; Schmitt J; Zamorano JL; Kirchhof P
    Thromb Haemost; 2014 May; 111(5):833-41. PubMed ID: 24651882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Vitamin K Antagonists and Brain Morphological Changes in Older Adults: An Exposed/Unexposed Voxel-Based Morphometric Study.
    Brangier A; Celle S; Roche F; Beauchet O; Ferland G; Annweiler C
    Dement Geriatr Cogn Disord; 2018; 45(1-2):18-26. PubMed ID: 29486479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic prophylaxis in elderly patients with atrial fibrillation.
    Hylek EM
    Semin Thromb Hemost; 2009 Sep; 35(6):548-53. PubMed ID: 19787558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necrotic leg ulcers induced by vitamin K antagonists: five cases].
    Bezier M; Perceau G; Reguiai Z; Remy-Leroux V; Tchen T; Durlach A; Grange F; Nguyen P; Bernard P
    Ann Dermatol Venereol; 2011 Oct; 138(10):657-63. PubMed ID: 21978501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants.
    Suárez-Pinilla M; Fernández-Rodríguez Á; Benavente-Fernández L; Calleja-Puerta S
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):732-42. PubMed ID: 23954605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What is the current use of vitamin K antagonists in the elderly?].
    Vidal JS; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation predicts cognitive impairment in patients with ischemic stroke.
    Mizrahi EH; Waitzman A; Arad M; Adunsky A
    Am J Alzheimers Dis Other Demen; 2011 Dec; 26(8):623-6. PubMed ID: 22218734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.